FDA Assures Public
Authorities at the Food and Drugs Authority (FDA), have said they are yet to establish the presence of contaminated palm oil in the Ghanaian market.
The assurance from FDA, follows news making rounds on social media about a seizure of two brands of palm oil (POLIFUDS and ZOMI) in Switzerland purported to contain Sudan dyes.
But in press release said “Preliminary investigations conducted so far by the FDA about the publication indicate that the implicated brands are not registered with the FDA and there is no information regarding the country of origin”.
It was signed by the Chief Executive Officer of FDA, Delese Mimi Darko.
The publication attributed to the Swiss Federal Food Safety and Veterinary Office (FSVO) and warned against the use of the said palm oil brands.
It may be recalled that, the FDA, has worked extensively on this subject in the past in collaboration with other agencies, including its European partners to ensure the safety of palm oil used in Ghana and for export.
“Market surveillance carried out so far by the FDA has also not established that the said brands are in circulation on the Ghanaian market”, the press statement said, adding “it must be noted that ZOMI is a generic name for a type of palm oil in many West African countries and its origin should not be necessarily associated with Ghana only”.
The FDA, wishes to assure the general public that it has put in place regulatory measures to ensure that palm oil on the Ghanaian market, as well as export consignments are safe for consumption.
The export control measures, include the sampling and testing of consignments for Sudan IV dyes among other parameters. Failed consignments are disposed of.
The FDA, will continue to monitor the industry and trade practices to promote public health and safety.
Meanwhile, the public is encouraged to alert the FDA on any issue regarding its mandate through any of the following contacts
Toll free: 0800151000(Vodafone and Airtel)
Hotlines: 0299802932, 0299802933
Short code: 4015